The Nasdaq Composite has been gaining ground for more than two years now. Its rise was driven by the dawn of artificial ...

The NASDAQ Composite Index is up 4299.44 points or 28.64% this year to 19310.79 --This quarter it is up 1121.62 points or 6.17% --Largest one-quarter point and percentage gain since the 2nd quarter ...

I recommend Lam Research as a strong buy for investors in 2025, citing positive technical indicators and attractive valuation ...

Here's why the S&P 500 is on track to rise more than 20% in two consecutive years for the first time since the late 1990s.

Progyny's valuation is deeply discounted, with strong fundamentals. Click here to read what makes PGNY stock an attractive ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

The Dow Jones fell on the stock market today. Magnificent Seven names Tesla and Apple stumbled. A Bill Ackman stock was lagging.

MicroStrategy's co-founder Michael Saylor has a history of posting on Sundays before his Bitcoin purchases the next day.

july 2022 satta chart FDA approves new radioactive contrast agent for improved PET scans AbCellera files for Nasdaq IPO, plans to raise $357 million Phase 2 clinical trial results of innovative ...

I have started a small position in QSI stock but remain cautious due to its low price, always trading with a stop loss for ...

kalyan satta chart Kangenbei Ambroxol Hydrochloride Oral Solution Obtained Drug Registration Approval Production exceeds 3M! The world's largest mask manufacturer was cut off by the United States A ...

dp boss kalyan chart The latest annual salary of medical representatives is announced PanGenomics applied for NASDAQ listing and suffered losses of over 400 million in the past two years Analysis of ...